home > drugs a-z list > serostim (somatropin (rdna origin)) drug center > serostim (somatropin (rdna origin)) drug - overdosage and contraindications

Recommended Topic Related To:

Serostim

Human Immunodeficiency Virus »

HIV facts

  • The human immunodeficiency virus (HIV) is a type of virus called a retrovirus, which infects humans when it comes in contact with tissues such as those that line the vagina, anal area, mouth, or eyes, or through a break in the skin.
  • HIV infection is generally a slowly progressive disease in which the virus is present throughout the body at all stages of the disease.
  • Three stages of HIV infection have been described.
    1. The initial stage of infection (primary infection), which occurs within weeks of acquiring the virus, and often is characterized by a flu- or mono-like illness that generally resolves within weeks.
    2. The stage of chronic asymptomatic infection (meaning a long duration of infection without symptoms) lasts an average of eight to 10 years.
    3. The stage of symptomatic infection, in which the body's immune (or defense) system has...

Read the Human Immunodeficiency Virus article »

Serostim

font size

OVERDOSE

Short-Term

Acute overdosage could lead initially to hypoglycemia and subsequently to hyperglycemia.

Long-Term

Long-term overdosage could result in signs and symptoms of acromegaly consistent with the known effects of excess growth hormone.

CONTRAINDICATIONS

Acute Critical Illness

Growth hormone therapy should not be initiated in patients with acute critical illness due to complications following open heart or abdominal surgery, multiple accidental trauma or acute respiratory failure. Two placebo-controlled clinical trials in non-growth hormone deficient adult patients (n=522) with these conditions revealed a significant increase in mortality (41.9% vs. 19.3%) among somatropin-treated patients (doses 5.3-8 mg/day) compared to those receiving placebo [see WARNING AND PRECAUTIONS].

Active Malignancy

In general, somatropin is contraindicated in the presence of active malignancy. Any preexisting malignancy should be inactive and its treatment complete prior to instituting therapy with somatropin. Somatropin should be discontinued if there is evidence of recurrent activity.

Diabetic Retinopathy

Somatropin is contraindicated in patients with active proliferative or severe non-proliferative diabetic retinopathy.

Hypersensitivity

Serostim® is contraindicated in patients with a known hypersensitivity to somatropin or diluent.

Last reviewed on RxList: 4/16/2012
This monograph has been modified to include the generic and brand name in many instances.

Additional Serostim Information

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Privacy Policy

WebMD Daily

Get breaking medical news.


From WebMD

Resources for Staying Well
Featured Centers
Health Solutions From Our Sponsors